Provided by Tiger Trade Technology Pte. Ltd.

Aldeyra Therapeutics

1.52
-0.0050-0.33%
Volume:447.51K
Turnover:675.69K
Market Cap:91.15M
PE:-3.95
High:1.55
Open:1.53
Low:1.46
Close:1.52
52wk High:6.18
52wk Low:1.07
Shares:60.16M
Float Shares:48.93M
Volume Ratio:0.58
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3836
EPS(LYR):-0.5636
ROE:-49.48%
ROA:-22.70%
PB:2.41
PE(LYR):-2.69

Loading ...

Aldeyra Therapeutics announces annual shareholder meeting

Reuters
·
Apr 28

April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair Value

Simply Wall St.
·
Apr 28

Aldeyra Therapeutics Faces Securities Lawsuit Over Reproxalap Trial Disclosures

TIPRANKS
·
Apr 23

Aldeyra Therapeutics Announces Upcoming Board Member Departure

TIPRANKS
·
Apr 21

Aldeyra director Martin Joyce will not stand for re-election at annual meeting

Reuters
·
Apr 21

ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky

TIPRANKS
·
Apr 17

Aldeyra Therapeutics Sued Over Alleged Misrepresentations About Key Drug Trial Data

TIPRANKS
·
Apr 03

Aldeyra Therapeutics Inc - Pays off $15 Mln Outstanding Borrowings, Terminates Hercules Credit Facility - SEC Filing

THOMSON REUTERS
·
Apr 02

Aldeyra Therapeutics repays $15 million, terminates Hercules credit facility

Reuters
·
Apr 02

Insider Makes Bold Move on Aldeyra Therapeutics Stock

TIPRANKS
·
Mar 21

Aldeyra Therapeutics Principal Financial Officer Michael Alfieri acquires USD 7,100 of common shares

Reuters
·
Mar 20

What's Going On With Aldeyra Therapeutics Stock On Thursday?

Benzinga_recent_news
·
Mar 19

Levi & Korsinsky probes Aldeyra Therapeutics over potential securities fraud claims

Reuters
·
Mar 19

Aldeyra Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Mar 18

HC Wainwright Downgrades Aldeyra Therapeutics to Neutral From Buy, Adjusts PT to $2 From $10

MT Newswires Live
·
Mar 18

Aldeyra downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
Mar 18

U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

Reuters
·
Mar 18

BUZZ-U.S. STOCKS ON THE MOVE -Steel Dynamics, Aldeyra, Cencora

Reuters
·
Mar 18

Aldeyra Therapeutics Shares Hit Record Low After US FDA Declines to Approve Eye Disorder Drug, Last Down 70%

THOMSON REUTERS
·
Mar 17

Aldeyra Therapeutics Shares Fall as Drug Rejected by Regulator on Efficacy Concerns

Dow Jones
·
Mar 17